Type 1 Diabetes Mellitus and Cognitive Impairments

A Systematic Review

Wei Li, Edgar Huang, Sujuan Gao

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Type 1 diabetes mellitus (T1DM) is a major subtype of diabetes and is usually diagnosed at a young age with insulin deficiency. The life expectancy of T1DM patients has increased substantially in comparison with that three decades ago due to the availability of exogenous insulin, though it is still shorter than that of healthy people. However, the relation remains unclear between T1DM and dementia as an aging-related disease. We conducted a systematic review of existing literature on T1DM and cognition impairments by carrying out searches in electronic databases Medline, EMBASE, and Google Scholar. We restricted our review to studies involving only human subjects and excluded studies on type 2 diabetes mellitus or non-classified diabetes. A meta-analysis was first performed on the relationship between T1DM and cognitive changes in youths and adults respectively. Then the review focused on the cognitive complications of T1DM and their relation with the characteristics of T1DM, glycemic control, diabetic complications, comorbidities, and others. First, age at onset, disease duration, and glycemic dysregulation were delineated for their association with cognitive changes. Then diabetic ketoacidosis, angiopathy, and neuropathy were examined as diabetic complications for their involvement in cognitive impairments. Lastly, body mass index and blood pressure were discussed for their relations with the cognitive changes. Future studies are needed to elucidate the pathogenesis of T1DM-related cognitive impairments or dementia.

Original languageEnglish (US)
Pages (from-to)29-36
Number of pages8
JournalJournal of Alzheimer's Disease
Volume57
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Type 1 Diabetes Mellitus
Diabetes Complications
Dementia
Insulin
Diabetic Angiopathies
Diabetic Ketoacidosis
Cognitive Dysfunction
Diabetic Neuropathies
Life Expectancy
Age of Onset
Type 2 Diabetes Mellitus
Cognition
Meta-Analysis
Comorbidity
Body Mass Index
Databases
Blood Pressure

Keywords

  • Cognitive impairments
  • diabetic ketoacidosis
  • microangiopathy
  • severe hypoglycemia
  • type 1 diabetes mellitus

ASJC Scopus subject areas

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Type 1 Diabetes Mellitus and Cognitive Impairments : A Systematic Review. / Li, Wei; Huang, Edgar; Gao, Sujuan.

In: Journal of Alzheimer's Disease, Vol. 57, No. 1, 2017, p. 29-36.

Research output: Contribution to journalReview article

@article{0c69f4dafe7b40c1a52f967275d16b8d,
title = "Type 1 Diabetes Mellitus and Cognitive Impairments: A Systematic Review",
abstract = "Type 1 diabetes mellitus (T1DM) is a major subtype of diabetes and is usually diagnosed at a young age with insulin deficiency. The life expectancy of T1DM patients has increased substantially in comparison with that three decades ago due to the availability of exogenous insulin, though it is still shorter than that of healthy people. However, the relation remains unclear between T1DM and dementia as an aging-related disease. We conducted a systematic review of existing literature on T1DM and cognition impairments by carrying out searches in electronic databases Medline, EMBASE, and Google Scholar. We restricted our review to studies involving only human subjects and excluded studies on type 2 diabetes mellitus or non-classified diabetes. A meta-analysis was first performed on the relationship between T1DM and cognitive changes in youths and adults respectively. Then the review focused on the cognitive complications of T1DM and their relation with the characteristics of T1DM, glycemic control, diabetic complications, comorbidities, and others. First, age at onset, disease duration, and glycemic dysregulation were delineated for their association with cognitive changes. Then diabetic ketoacidosis, angiopathy, and neuropathy were examined as diabetic complications for their involvement in cognitive impairments. Lastly, body mass index and blood pressure were discussed for their relations with the cognitive changes. Future studies are needed to elucidate the pathogenesis of T1DM-related cognitive impairments or dementia.",
keywords = "Cognitive impairments, diabetic ketoacidosis, microangiopathy, severe hypoglycemia, type 1 diabetes mellitus",
author = "Wei Li and Edgar Huang and Sujuan Gao",
year = "2017",
doi = "10.3233/JAD-161250",
language = "English (US)",
volume = "57",
pages = "29--36",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Type 1 Diabetes Mellitus and Cognitive Impairments

T2 - A Systematic Review

AU - Li, Wei

AU - Huang, Edgar

AU - Gao, Sujuan

PY - 2017

Y1 - 2017

N2 - Type 1 diabetes mellitus (T1DM) is a major subtype of diabetes and is usually diagnosed at a young age with insulin deficiency. The life expectancy of T1DM patients has increased substantially in comparison with that three decades ago due to the availability of exogenous insulin, though it is still shorter than that of healthy people. However, the relation remains unclear between T1DM and dementia as an aging-related disease. We conducted a systematic review of existing literature on T1DM and cognition impairments by carrying out searches in electronic databases Medline, EMBASE, and Google Scholar. We restricted our review to studies involving only human subjects and excluded studies on type 2 diabetes mellitus or non-classified diabetes. A meta-analysis was first performed on the relationship between T1DM and cognitive changes in youths and adults respectively. Then the review focused on the cognitive complications of T1DM and their relation with the characteristics of T1DM, glycemic control, diabetic complications, comorbidities, and others. First, age at onset, disease duration, and glycemic dysregulation were delineated for their association with cognitive changes. Then diabetic ketoacidosis, angiopathy, and neuropathy were examined as diabetic complications for their involvement in cognitive impairments. Lastly, body mass index and blood pressure were discussed for their relations with the cognitive changes. Future studies are needed to elucidate the pathogenesis of T1DM-related cognitive impairments or dementia.

AB - Type 1 diabetes mellitus (T1DM) is a major subtype of diabetes and is usually diagnosed at a young age with insulin deficiency. The life expectancy of T1DM patients has increased substantially in comparison with that three decades ago due to the availability of exogenous insulin, though it is still shorter than that of healthy people. However, the relation remains unclear between T1DM and dementia as an aging-related disease. We conducted a systematic review of existing literature on T1DM and cognition impairments by carrying out searches in electronic databases Medline, EMBASE, and Google Scholar. We restricted our review to studies involving only human subjects and excluded studies on type 2 diabetes mellitus or non-classified diabetes. A meta-analysis was first performed on the relationship between T1DM and cognitive changes in youths and adults respectively. Then the review focused on the cognitive complications of T1DM and their relation with the characteristics of T1DM, glycemic control, diabetic complications, comorbidities, and others. First, age at onset, disease duration, and glycemic dysregulation were delineated for their association with cognitive changes. Then diabetic ketoacidosis, angiopathy, and neuropathy were examined as diabetic complications for their involvement in cognitive impairments. Lastly, body mass index and blood pressure were discussed for their relations with the cognitive changes. Future studies are needed to elucidate the pathogenesis of T1DM-related cognitive impairments or dementia.

KW - Cognitive impairments

KW - diabetic ketoacidosis

KW - microangiopathy

KW - severe hypoglycemia

KW - type 1 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=85015229310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015229310&partnerID=8YFLogxK

U2 - 10.3233/JAD-161250

DO - 10.3233/JAD-161250

M3 - Review article

VL - 57

SP - 29

EP - 36

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -